[BSX] Boston Scientific Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 21.81 Change: 0.15 (0.69%)
Ext. hours: Change: 0 (0%)

chart BSX

Refresh chart

Strongest Trends Summary For BSX

BSX is in the long-term up 25% above S&P in 3 years and up 357% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS0.73 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.61% Sales Growth - Q/Q-6.31% P/E38.01
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-1.54% ROE-3.89% ROI-1.94%
Current Ratio1.29 Quick Ratio0.91 Long Term Debt/Equity5.3 Debt Ratio0.38
Gross Margin70.26% Operating Margin-6.43% Net Profit Margin-3.43% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-94 M Cash From Investing Activities-51 M Cash From Operating Activities-197 M Gross Profit1.3 B
Net Profit102 M Operating Profit219 M Total Assets17.12 B Total Current Assets3.77 B
Total Current Liabilities1.94 B Total Debt5.11 B Total Liabilities10.54 B Total Revenue1.84 B
Technical Data
High 52 week43.45 Low 52 week31.73 Last close38.46 Last change1.29%
RSI32.22 Average true range1.16 Beta0.9 Volume4.25 M
Simple moving average 20 days-4.97% Simple moving average 50 days-7.45% Simple moving average 200 days-2.99%
Performance Data
Performance Week1.56% Performance Month-8.3% Performance Quart-8.95% Performance Half6.33%
Performance Year3.97% Performance Year-to-date8.83% Volatility daily2.11% Volatility weekly4.71%
Volatility monthly9.65% Volatility yearly33.42% Relative Volume246.39% Average Volume6.14 M
New High New Low

News

2020-06-01 06:50:00 | Boston Scientific Launches DIRECTSENSE™ Technology

2020-05-29 13:13:05 | 8 Stocks Viking Global Investors Continues to Buy

2020-05-29 11:31:03 | How Has BSX Performed 30 Days Post Earnings

2020-05-27 19:01:00 | Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock

2020-05-26 15:07:25 | Hedge Funds Have Never Been This Bullish On Boston Scientific BSX

2020-05-26 09:30:00 | Boston Scientific to Participate in Jefferies 2020 Healthcare Conference

2020-05-21 21:52:00 | Boston Scientific Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock

2020-05-21 12:15:00 | Boston Scientific Aims to Raise $1.5 Billion in Two Offerings

2020-05-21 03:06:25 | Boston Scientific Sinks on $1.5B Capital Raise Announcement

2020-05-20 16:19:00 | Boston Scientific Announces Offerings of Common Stock and Mandatory Convertible Preferred Stock

2020-05-19 16:01:07 | Boston Scientific: Fast-Growing Earnings Get the Attention of Gurus

2020-05-19 13:16:30 | 7 Stocks Elfun Trusts Continues to Buy

2020-05-18 19:26:32 | Daniel Loeb Exits Campbell Soup and Trims Baxter in the 1st Quarter

2020-05-18 17:00:00 | Boston Scientific Completes $1.7 Billion Offering of Senior Notes

2020-05-18 16:19:07 | Boston Scientific Corporation -- Moody's announces completion of a periodic review of ratings of Boston Scientific Corporation

2020-05-18 15:49:20 | Third Point Exits Campbell Soup, Trims Baxter International

2020-05-14 18:20:00 | Boston Scientific Prices $1.7 Billion of Senior Notes

2020-05-14 08:59:07 | Boston Scientific Corporation -- Moody's assigns Baa2 rating to Boston Scientific's senior unsecured note offering

2020-05-12 10:01:25 | Is Boston Scientific BSX The Best Medical Devices Stock?

2020-05-11 11:02:29 | Stocks in My Do Nothing Club May Just Wake Up

2020-05-08 09:00:00 | Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System

2020-05-08 09:00:00 | PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

2020-05-06 09:30:00 | Boston Scientific Announces May 2020 Virtual Conference Schedule

2020-05-04 13:36:11 | Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio

2020-05-03 16:03:01 | Were Hedge Funds Right About Boston Scientific Corporation BSX?

2020-05-01 11:40:03 | PETQ vs. BSX: Which Stock Should Value Investors Buy Now?

2020-05-01 11:27:03 | 3 Stocks With Fast-Growing Earnings

2020-04-30 01:31:55 | Boston Scientific BSX Q1 2020 Earnings Call Transcript

2020-04-30 00:08:54 | Edited Transcript of BSX earnings conference call or presentation 29-Apr-20 12:00pm GMT

2020-04-29 18:00:00 | Boston Scientific Stock Rises on Sales Increase, Positive Management Outlook

2020-04-29 16:41:21 | Medtech Leader Reports Lagging Earnings As Coronavirus Takes A Hit

2020-04-29 11:29:03 | Boston Scientific BSX Q1 Earnings Miss, Margins Decline

2020-04-29 11:15:12 | Covid-19 Hurting Sales of Medtech Companies

2020-04-29 08:53:00 | Boston Scientific Delivers Decent Q1, but We Expect Significant COVID-19 Impact on the Full Year

2020-04-29 07:55:11 | Boston Scientific BSX Q1 Earnings Miss Estimates

2020-04-29 06:30:00 | Boston Scientific Announces Results For First Quarter 2020

2020-04-28 11:31:03 | Medical Products Stock Earnings on Apr 29: BSX, ALGN & More

2020-04-23 13:29:00 | 'Light' ventilator uses robotic arm and resuscitation bag to help with coronavirus

2020-04-23 13:29:00 | 'Light' ventilator uses robotic arm and resuscitation bag to help with coronavirus

2020-04-23 11:16:03 | Can IC and PI Arms Drive Boston Scientific BSX Q1 Earnings?

2020-04-22 15:36:19 | How the $484B stimulus bill will impact the healthcare sector

2020-04-22 12:31:04 | Analysts Estimate Boston Scientific BSX to Report a Decline in Earnings: What to Look Out for

2020-04-21 08:00:00 | New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half

2020-04-20 18:45:00 | Boston Scientific Shows Rising Relative Strength Despite Revenue Slide

2020-04-16 07:00:00 | Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals

2020-04-16 00:34:35 | Global Cases Top 2 Million; United Braces for Cuts: Virus Update

2020-04-15 16:47:43 | Andreas Halvorsen Checks Into Zentalis Pharmaceuticals

2020-04-15 15:47:01 | FDA approves University of Minnesota's 'MacGyver'-esque ventilator

2020-04-14 23:30:14 | Trump Stops WHO Funds; Indonesia Broadens Lockdown: Virus Update

2020-04-10 09:30:00 | Boston Scientific Announces 2020 Annual Meeting of Stockholders Will Be Conducted in Virtual Format